These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3462003)

  • 1. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.
    Terziivanov D; Gerova Z; Vlahov V; Merdzhanov A; Damjanov D
    Eur J Clin Pharmacol; 1986; 30(4):439-44. PubMed ID: 3462003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization of the pathways of cefotiam elimination by clearance approaches in patients following cholecystectomy].
    Terziivanov D; Gerova Z; Vlakhov V
    Vutr Boles; 1985; 24(6):84-9. PubMed ID: 3868221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary elimination of cefotiam, an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Levy P; Dorner M; Lautier F
    Chemotherapy; 1986; 32(3):222-35. PubMed ID: 3458565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of the cephalosporin antibiotic cefotiam following its intravenous administration to patients after cholecystectomy].
    Terziivanov D; Gerova Z; Vlakhov V
    Vutr Boles; 1986; 25(6):86-91. PubMed ID: 3471005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies on excretion in biliary tract with the antibiotic cefotiam].
    Yaita A; Kanamori H; Masuo K; Taniura H; Nakamura T
    Jpn J Antibiot; 1985 Jun; 38(6):1566-70. PubMed ID: 3862879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefotiam in humans.
    Rouan MC; Lecaillon JB; Guibert J; Modai J; Schoeller JP
    Antimicrob Agents Chemother; 1985 Feb; 27(2):177-80. PubMed ID: 3857018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentrations of cefmenoxime and cefotiam in the bile and gallbladder tissue following intravenous administration in patients with biliary tract diseases].
    Shoda Y; Matsuyama S; Takarada A; Arai M; Nagashima K; Nakano G; Nakamura T; Kamisaka K; Matsuzawa T; Yoshino T
    Jpn J Antibiot; 1986 May; 39(5):1259-72. PubMed ID: 3463776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefotiam in normal humans.
    Daschner FD; Hemmer KA; Offermann P; Slanicka J
    Antimicrob Agents Chemother; 1982 Dec; 22(6):958-60. PubMed ID: 6297387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinical study on cefotiam with special reference to excretion in bile and concentration in gallbladder tissue].
    Nishimura O; Kohno K; Sumikawa M; Kawamura Y; Hisaki T; Odachi T; Ogawa H; Kishi K; Koga S
    Jpn J Antibiot; 1984 Feb; 37(2):219-28. PubMed ID: 6330391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ursodeoxycholate on the biliary excretion of cefotiam and sulbenicillin in patients with percutaneous transhepatic biliary drainage.
    Higashi K; Hayakawa T; Katagiri K; Tsukada K; Ito K; Hoshino M; Miyaji M; Takeuchi T; Yamamoto T
    Antimicrob Agents Chemother; 1988 May; 32(5):726-9. PubMed ID: 3164988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Ozawa Y
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory and clinical investigations of cefotiam in surgical biliary tract infections].
    Oikawa M; Watanabe I
    Jpn J Antibiot; 1982 May; 35(5):1153-62. PubMed ID: 6290699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on penetration of antibiotics to gallbladder tissue and bile, its surgical significance. Mainly with cefmenoxime].
    Tsuburaya H; Watanabe I; Endo S; Oikawa M
    Jpn J Antibiot; 1985 Jan; 38(1):31-40. PubMed ID: 3857360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical observation on the transport of cefotiam into the bile and gall bladder tissue].
    Tohyama K; Miyake T; Morinaga H; Futakuchi S; Izumi M; Yamanaka T; Egami H; Yamane T; Ga S; Fujishima K
    Jpn J Antibiot; 1983 Jun; 36(6):1439-42. PubMed ID: 6317904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of experimentally induced cholestasis on the pharmacokinetics of cefotiam.
    Alonso IG; Mariño EL; Dominguez-Gil A
    Arzneimittelforschung; 1984; 34(7):798-800. PubMed ID: 6093824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ursodeoxycholic acid on biliary excretion of cefotiam in patients with percutaneous transhepatic biliary drainage].
    Hayakawa T; Higashi K; Katagiri K; Miyaji M; Tsunoka S; Inaguma H; Tohyama K; Hoshino M; Ito M; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Mar; 82(3):483-8. PubMed ID: 3859677
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical studies on the transference of cephem-type antibiotics into bile and gallbladder tissues with special reference to cefotiam and cefmenoxime].
    Shiozaki H; Aeba S; Matsumoto H; Usui R; Totsuka S; Kusaba T; Mishima T; Hasegawa S; Iijima K; Okano A
    Jpn J Antibiot; 1986 Mar; 39(3):751-60. PubMed ID: 3461175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of ceftizoxime in humans.
    Brogard JM; Arnaud JP; Timmler R
    Chemotherapy; 1984; 30(4):221-6. PubMed ID: 6086245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.